权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Mechanistic basis of bacteriophages for the decolonization of vancomycin resistant enterococci in the intestine.

噬菌体对肠道内万古霉素耐药肠球菌去定植的机制基础。

基本信息

批准号：
10228669
负责人：
Breck A Duerkop
金额：
$ 37.76万
依托单位：
UNIVERSITY OF COLORADO DENVER
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-09-14 至 2023-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10228669
关键词：
Antibiotic Resistance Antibiotic Therapy Antibiotics Bacteremia Bacteria Bacterial Antibiotic Resistance Bacterial Infections Bacteriophages Binding Biological Products Blood Circulation Cell Wall Clinic Communities Development Drug resistance Enterococcus Enterococcus faecalis Environment Evolution Future Genome Genome Stability Genomics Germ-Free Goals Gram-Positive Bacteria Habitats Hospitals Human In Vitro Incidence Individual Infection Intestines Knowledge Lead Mediating Modeling Molecular Molecular Genetics Multi-Drug Resistance Multiple Bacterial Drug Resistance Mus Mutation Natural Immunity Nosocomial Infections Oral Administration Outcome Phage Receptors Physiological Population Predatory Behavior Process Resistance Resort Sepsis Site Specificity Therapeutic Therapeutic Intervention Tissues Vancomycin Vancomycin resistant enterococcus Virus bacterial fitness bacterial resistance base combat experience experimental study genome sequencing gut colonization gut microbiota in vivo insight microbiota novel novel therapeutic intervention novel therapeutics opportunistic pathogen pathogenic bacteria plasmid DNA pressure receptor receptor function resistant strain standard of care trait treatment strategy whole genome

项目摘要

Project Summary/Abstract The incidence of multidrug resistant (MDR) bacterial infections is rising. This is particularly relevant for the Gram- positive bacterium Enterococcus faecalis, an opportunistic pathogen and leading cause of nosocomial bacteremia. The rise in MDR E. faecalis infections is largely attributed to their ability to resist many antibiotics including antibiotics of “last resort”, such as vancomycin. E. faecalis is a native inhabitant of the human intestinal tract which serves as a major reservoir of MDR E. faecalis. Antibiotic depletion of the intestinal microbiota can facilitate blooms of E. faecalis leading to their enhanced dissemination to the bloodstream and other tissue sites. In many cases overgrowth of intestinal enterococci is dominated by vancomycin resistant enterococci (VRE) which severely limits available treatment options. With increasing VRE infections worldwide, it is imperative that new strategies for therapeutic intervention are explored. An alternative to traditional antibiotics is the use of biological agents for the treatment of drug resistant bacterial infections. One approach is harnessing bacteriophages (phages) that infect and kill bacteria. Although phages may hold promise as next generation therapeutics, we know little of the basic principles of phage infection processes in vivo and how the mammalian host environment influences phage-bacteria interactions. This project investigates the use of phages for the decolonization of VRE within its natural intestinal habitat. Using a combination of mouse intestinal colonization models, molecular genetics and whole genome sequencing, we aim to gain mechanistic insight into how intestinal selective pressures influence the infectivity and genome evolution of phages during phage-mediated VRE decolonization. To achieve this goal we will execute three specific aims: 1) Define the intestinal selective pressures that dictate phage-mediated E. faecalis decolonization, 2) Determine the long-term stability and genomic evolution of E. faecalis phages in the intestine, and 3) Determine cognate receptors for diverse E. faecalis phages and delineate receptor function. Understanding intestinal selective pressures and molecular mechanisms of enterococcal phage infection in vivo will aid in the development of novel phage therapeutics for the decolonization of enterococci recalcitrant to conventional antibiotics.

项目总结/文摘